Time: Every Thursday at 12:20pm - 1:20pm

Cancer Research Building 2, 1550 Orleans St, 1M.13
Baltimore, MD

Bedaquiline (previously R207910, then TMC207) is a firstin- class diarylquinolone antibiotic that was initially approved for the...

SETTING: Multidrug-resistant tuberculosis (MDR-TB) unit in KwaZulu-Natal, South Africa. OBJECTIVE: To develop and evaluate a...

Editorial 

Background Tuberculosis (TB) is an occupational hazard for health care workers (HCWs) who are at greater risk of developing TB...

BACKGROUND: Tackling the social determinants of Tuberculosis (TB) through social protection is a key element of the post-2015...